Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Ductal; Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05475366
What this trial is testing

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures

Who this might be right for
Carcinoma, Pancreatic DuctalPrognosis
Institut Curie 85
Early research (Phase 1)Study completedNCT02259114
What this trial is testing

A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)

Who this might be right for
NUT Midline CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation+3 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 47
Large-scale testing (Phase 3)Not Yet RecruitingNCT07445295
What this trial is testing

Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Chipscreen Biosciences, Ltd. 558
Testing effectiveness (Phase 2)Study completedNCT02583477
What this trial is testing

Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
AstraZeneca 23
Testing effectiveness (Phase 2)UnknownNCT03634332
What this trial is testing

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreatic Neoplasms
Pancreatic Cancer Research Team 35
Testing effectiveness (Phase 2)Looking for participantsNCT07627711
What this trial is testing

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally AdvancedMetastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)Study completedNCT01839487
What this trial is testing

PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Halozyme Therapeutics 279
Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Not applicableLooking for participantsNCT07155850
What this trial is testing

Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Locally AdvancedUnresectable
BetaGlue Therapeutics SpA 10
Not applicableStudy completedNCT05476978
What this trial is testing

Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatitis, ChronicPancreatic Neuroendocrine Tumor+1 more
Huazhong University of Science and Technology 130
Not applicableLooking for participantsNCT05630989
What this trial is testing

A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Mandana Kamgar, MD 80
Testing effectiveness (Phase 2)Ended earlyNCT05289830
What this trial is testing

Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPeriampullary Cancer
Case Comprehensive Cancer Center 4
Not applicableActive Not RecruitingNCT04449406
What this trial is testing

Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Queen Mary University of London 3,500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07153289
What this trial is testing

CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)

Who this might be right for
Carcinoma, Pancreatic DuctalPancreatic Neoplasms
University Hospital Tuebingen 38
Early research (Phase 1)Looking for participantsNCT06179160
What this trial is testing

Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Who this might be right for
Solid Tumors
Incyte Corporation 710
Not applicableEnrolling By InvitationNCT07241676
What this trial is testing

Early Recurrence After Surgery for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Recurrent Pancreatic Adenocarcinoma
Azienda Ospedaliera di Padova 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07745790
What this trial is testing

Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaLiver NeoplasmsLung Neoplasms
Ruijin Hospital 20
Very early researchTemporarily pausedNCT04975217
What this trial is testing

Fecal Microbial Transplants for the Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
M.D. Anderson Cancer Center 10
Early research (Phase 1)Looking for participantsNCT07024615
What this trial is testing

ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Astellas Pharma Global Development, Inc. 25
Early research (Phase 1)Looking for participantsNCT07227168
What this trial is testing

STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more
Sutro Biopharma, Inc. 200
Next Page